On Friday, OptimizeRx Corp (NASDAQ: OPRX) was 8.46% up from the session before settling in for the closing price of $4.49. A 52-week range for OPRX has been $3.78 – $16.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 30.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 9.62%. With a float of $15.96 million, this company’s outstanding shares have now reached $18.16 million.
The firm has a total of 136 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.39%, operating margin of -32.03%, and the pretax margin is -37.8%.
OptimizeRx Corp (OPRX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward OptimizeRx Corp stocks. The insider ownership of OptimizeRx Corp is 13.36%, while institutional ownership is 67.29%. The most recent insider transaction that took place on Jan 09 ’24, was worth 60,751. In this transaction General Counsel and CCO of this company sold 4,000 shares at a rate of $15.19, taking the stock ownership to the 11,114 shares.
OptimizeRx Corp (OPRX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.26 earnings per share (EPS) during the time that was less than consensus figure (set at 0.27) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.62% per share during the next fiscal year.
OptimizeRx Corp (NASDAQ: OPRX) Trading Performance Indicators
You can see what OptimizeRx Corp (OPRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.33, a number that is poised to hit 0.25 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of OptimizeRx Corp (OPRX)
Analysing the last 5-days average volume posted by the [OptimizeRx Corp, OPRX], we can find that recorded value of 0.48 million was better than the volume posted last year of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 28.79%. Additionally, its Average True Range was 0.53.
During the past 100 days, OptimizeRx Corp’s (OPRX) raw stochastic average was set at 14.06%, which indicates a significant decrease from 35.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 206.66% in the past 14 days, which was higher than the 92.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.30, while its 200-day Moving Average is $9.90. Now, the first resistance to watch is $5.11. This is followed by the second major resistance level at $5.34. The third major resistance level sits at $5.66. If the price goes on to break the first support level at $4.55, it is likely to go to the next support level at $4.23. Should the price break the second support level, the third support level stands at $4.00.
OptimizeRx Corp (NASDAQ: OPRX) Key Stats
There are 18,421K outstanding shares of the company, which has a market capitalization of 97.30 million. As of now, sales total 71,520 K while income totals -17,570 K. Its latest quarter income was 21,310 K while its last quarter net income were -9,120 K.
